Detailed Description

Update

Targacept, Inc. is a biopharmaceutical company developing a diverse pipeline of NNR TherapeuticsTM. NNR Therapeutics selectively target neuronal nicotinic receptors, or NNRs. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity.

Current Team (2)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • Headquarters

    200 East First Street

    Suite 300

    Winston Salem, NC 27101-4165

    USA

News (1)

Update

Images (1)

Update
  • E33fb26b5f2cd3643f232692292b4662